Cahn Medical Technologies (CMT) was established in 2002 by Charles Cahn, formerly Senior Managing Director of Research Services at Sanford C. Bernstein & Co., Inc. The company was formed to focus exclusively on early-stage medical technology ventures. Investments in a company typically range from
$1-$3 million.
Our differentiating features include:
- Willingness to invest early in a company’s development
- Long-term investment horizon
- Interface exclusively with the senior partner
- Focus on companies with medium-sized market opportunities
Our culture has these characteristics:
- Focused
- Collaborative
- Supportive when times get tough
- Ethical
|  |
